Announcing the 2025 Warren Alpert Foundation Prize Awardees Learn more

Celebrating the Transformative Impact of Computer Tools and Databases in Biomedicine

Each year the recipient(s) of the Warren Alpert Foundation Prize are recognized at a scientific symposium hosted by Harvard Medical School.

2023 Warren Alpert Foundation Prize Symposium

In honor of: David J. Lipman MD Senior Science Advisor for Bioinformatics and Genomics Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration for his vision and generation of computational tools, databases and infrastructure that changed the way biological information can be rapidly and freely exchanged, searched, and analyzed, thus enabling discovery of fundamental biological mechanisms, their alterations in disease, and potential as new therapeutic targets.

David Lipman

David Lipman | 2023 Recipient

Dr. David Lipman worked at the National Institutes of Health for 36 years and served as the founding Director of the National Center for Biotechnology Information (NCBI) at the National Library of Medicine/NIH. Under Dr. Lipman’s leadership, NCBI created and managed some of the most heavily used biomedical information resources including PubMed, PubMed Central, GenBank, SRA, and RefSeq. In 2014, Dr. Lipman also led the team at NCBI that developed the computational genomics resources used by the FDA and CDC to identify foodborne outbreaks more rapidly and to determine the source of contamination. He is currently Senior Science Advisor in Bioinformatics and Genomics at FDA’s Center for Food Safety and Applied Nutrition.

From 2017 through 2019, Dr. Lipman served as Chief Science Officer for plant-based meat company Impossible Foods. He directed the team that developed and commercialized the current Impossible Burger, the Impossible Whopper, and the sausage and ground pork formulations.

Dr. Lipman’s research has focused on molecular evolution, molecular epidemiology, comparative genomics, and the development of computational tools including the computational tool, BLAST, for biological sequence comparison and database search. His research papers have been cited by over 250,000 scientific publications. Dr. Lipman is an elected member of the National Academy of Sciences, the National Academy of Medicine, and the American Academy of Arts and Sciences.

Symposium Program

Each year the recipient(s) of the Warren Alpert Foundation Prize are recognized at a scientific symposium hosted by Harvard Medical School.

Watch the full program

Opening Remarks

George Q. Daley, MD,

Dean of the Faculty of Medicine, Harvard University; Caroline Shields Walker Professor of Medicine

Vamsi Mootha, MD

Professor of Systems Biology, Harvard Medical School and Massachusetts General Hospital; Investigator, Howard Hughes Medical Institute

Award Lecture

David J. Lipman, MD

Invited Speakers

Eugene V. Koonin, PhD

Distinguished Investigator, Evolutionary Genomics Group Leader; National Institutes of Health

Debora Marks, PhD

Professor of Systems Biology, Harvard Medical School; Associate Member, Broad Institute of MIT and Harvard

David C. Page, MD

Member, Whitehead Institute; Professor of Biology, Massachusetts Institute of Technology; Investigator, Howard Hughes Medical Institute

Olga Troyanskaya, PhD

Director, Princeton Precision Health; Professor in the Department of Computer Science and the Lewis-Sigler Institute for Integrative Genomics, Princeton University; Deputy Director for Genomics, Flatiron Institute’s Center for Computational Biology

Sign up to receive updates

Sign up to receive updates

Past Symposia

For questions about the prize, please contact us.

Contact Us
I am delighted to be in such good company—and I’m not talking just about my co-laureates. Many of my scientific heroes are among the previous recipients of the Prize.
- Gero Miesenböck

Gero Miesenböck | 2019 Recipient

Gero Miesenböck is Waynflete Professor of Physiology and founding Director of the Centre for Neural Circuits and Behaviour at the University of Oxford. Before coming to Oxford in 2007, he held faculty appointments at Memorial Sloan-Kettering Cancer Center and Yale University. Miesenböck was the first scientist to modify neurons genetically so that their electrical activity could be controlled with light. This involved inserting DNA for light-responsive opsin proteins into the cells. He used similar genetic modifications to breed animals whose brains contained light-responsive neurons integrated into their circuitry and was the first to demonstrate that the behavior of these animals could be remote-controlled. Miesenböck has received many awards for the invention of optogenetics, including the InBev-Baillet Latour International Health Prize, the Brain Prize, the Heinrich Wieland Prize, the BBVA Foundation Frontiers of Knowledge Award, and the Massry Prize. He is a member of the Austrian and German Academies of Sciences and a Fellow of the Royal Society.

 View Past Recipients